Publikationsserver
Dimethyl fumarate suppresses Tc17 cell fate in autoimmunity via ROS accumulation
Dimethyl fumarate (DMF) is approved for treatment of relapsing remitting multiple sclerosis (RRMS), a chronic inflammatory disease of the central nervous system (CNS) that is caused by autoreactive T cells. The effect mechanism of DMF is not fully elucidated so far; however, a preferential impact on...
Збережено в:
| Автор: | |
|---|---|
| Інші автори: | |
| Формат: | Dissertation |
| Мова: | англійська |
| Опубліковано: |
Philipps-Universität Marburg
2018
|
| Предмети: | |
| Онлайн доступ: | PDF-повний текст |
| Теги: |
Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|
No citations were found for this record.